1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThree receipt cycles annually: April 8, August 8, December 8 (5 pm local time)
NCI F31 Award is sponsored by National Cancer Institute (NCI). Provides fellowships for predoctoral students to obtain individualized, mentored research training in cancer-related fields.
Get alerted about grants like this
Save a search for “National Cancer Institute (NCI)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Ruth L. Kirschstein National Research Service Award (NRSA) for Individual Predoctoral Fellows (F31) The NCI Ruth L. Kirschstein NRSA for Individual Predoctoral Fellows (F31) Award supports promising doctoral candidates who will perform dissertation research and training for a PhD degree in a scientific health-related field relevant to the mission of the NCI during the tenure of the award.
Applicants for the F31 must be candidates for the PhD degree and must be at the dissertation research stage of training at the time of award. NCI requires a clear cancer focus in the research training plan. Since the fellowship award does not support research costs, NCI gives funding priority to applications clearly indicating funds are available to support the candidate’s research training plan throughout the duration of the award.
Note: The details on this page are for informational purposes only. Please read and follow all requirements and instructions in the notice of funding opportunity (NOFO) and the Table of IC-Specific Information linked therein before applying for an award. Application review information is described in the funding opportunity.
If you have any questions before submitting your application, please contact the relevant NCI program staff listed at the end of this page. General Award Information Frequently Asked Questions Do you have questions about your NCI application or award for training in cancer research or education? Make the NCI Frequently Asked Questions your first stop to getting answers!
NCI-specific guidance on overlap between F31 fellowship applications and the sponsor’s pending/active grants: The F31 Research Training Plan should be developed in collaboration between the sponsor and F31 candidate. The F31 project can be within the overall scope of the active sponsor’s research awards.
However, NCI expects the F31 candidate to make significant intellectual contributions to the project and write the Research Training Plan. There should be no text duplication or substantial duplication of the scientific aims, and the candidate ’s application should propose a scientific research question or approach that is distinct from the specific aims of the sponsor’s pending or active research grants.
NCI will not support both a fellowship award and an active or pending research grant that propose substantially the same research. For more complete information, please refer to the Program Announcement PA-25-422 (F31 Individual Predoctoral Fellowship) and/or contact the program staff.
Citizenship At the time of the award, the candidate must be: or a non-citizen national, or must have been lawfully admitted for permanent residence and possess an Alien Registration Receipt Card (1-151 or 1-551) or some other verification of legal admission as a permanent resident. The candidate does not need citizenship or a green card to apply. Citizenship or green card is needed at the time of award issuance.
Foreign Nationals with Student Visas Not eligible for this award Degree/Academic Appointment Predoctoral Fellows Geographic Location F31 Fellows may request support for training abroad; clear scientific justification is required, including the reasons why the facilities, the sponsor, and/or other aspects of the proposed experience are more appropriate than training in a domestic setting.
Effort Level/ Commitment At least 40 hours per week, full-time effort, to the training program Duration of the Award Up to 5 years; individual fellowship awards are generally not renewable; consult NIH staff to obtain advice regarding submission of a renewal application for additional fellowship support Tuition, Fees, Training-Related Expenses and Health Insurance (for non-federal Public, Private, and Non-Profit Institutions) Tuition and Fees NCI will pay 60% of the combined amount requested for tuition and fees up to $16,000 per year.
Training-Related Expenses and Health Insurance NCI will pay up to $4,750 annually to help defray other research training expenses, such as: Health insurance (self-only or family, as applicable) Travel to scientific meetings Required Application Instructions Applications must be submitted electronically It is critical that applicants follow the instructions in the SF424 (R&R) Fellowship Application Guide, as well as any program-specific instructions noted in Section IV.
of the Program Announcement. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not be accepted for review.
For assistance with application submission, please refer to the Frequently Asked Questions and/or contact eRA Commons Help Desk/Grant. gov Contact Center.
Application Receipt Dates and Review Schedule Receipt Cycle Receipt Date: New, Resubmission Initial Review Date Council Review Date Earliest Possible Start Date* 1 April 8 June/July September/October December 2 August 8 October/November January/February April 3 December 8 February/March May/June July *Start dates are determined by the availability of NCI funds and may not occur until well after the earliest possible start date.
Applications are due by 5 pm local time. When a standard submission date falls on a weekend or Federal holiday , the application deadline is automatically extended to the next business day. Review and Selection Process The Center for Scientific Review (CSR) and the National Cancer Institute (NCI) review applications for completeness and for conformance to all eligibility requirements and special provisions and requirements.
Incomplete applications will be returned to the applicant without further consideration. For review criteria for the F31 grant mechanism, see the Section V. Review Information of the Program Announcement.
Reminders for Awardees including Changes in Project and Terminations 1. Changes in the Project : Individual NCI F31 fellowship awards are made for training at a specific institution under the guidance of a particular sponsor. Prior approval by NCI is required for a transfer of the award to another institution, a change in sponsor, or a significant project change.
If the primary sponsor plans to be absent for a continuous period of more than 3 months, an interim sponsor must be named by the institution and approved in writing by NCI. 2. Termination Requirements: F31 awardees are required to submit a Termination Notice either when: all institutional doctoral degree requirements have been completed; or the F31 project end date listed on the Notice of Award (NoA) has arrived (whichever comes first).
F31 awardees are required to submit a Termination Notice within 30 days of the conclusion of award funding. Program Announcement PA-25-422 (F31 Individual Predoctoral Fellowship) Foundations of Success: NCI Fellowship Awards Explained (F Awards) Current List of F31 Awards Link to Peer Review Groups Overview of the Grant Process NCI Resources for Researchers NIH Grants Policy Statement (GPS) - see section 11.
2 Termination Notice : Terminations are submitted via xTrain by the institution's business official For additional information regarding policies and/or guidance in preparing an application, contact: For assistance with xTrain, contact: xTrain Program Specialist For technical issues with xTrain, contact the eRA Service Desk For information regarding fiscal and/or budget issues, contact: Office of Grants Administration Email: NCIFinancialContact@nih.
gov For information regarding referral issues, contact: Email: ncirefof@dea. nci. nih.
gov For information regarding review issues, contact: Center for Scientific Review, Division of Receipt & Referral Email: csrdrr@mail. nih. gov Scientific Review Officer Email: found in your eRA Commons account
Based on current listing details, eligibility includes: Doctoral candidates (PhD) pursuing cancer-focused dissertation research; U.S. citizens, non-citizen nationals, or permanent residents; full-time commitment required. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates $29,364/year stipend; 60% tuition/fees up to $16,000/year; up to $4,750/year training expenses Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) is sponsored by National Cancer Institute (NCI). This NOFO encourages applications promoting transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. It specifically mentions the integration of modeling and simulation approaches to guide rational nanomaterial design and the use of artificial intelligence (AI) and modeling to aid rational drug design. This directly relates to personalized medicine and cancer treatment, though the primary focus is nanotechnology.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
NIH NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00) is a grant from the National Institutes of Health (NIH) / National Cancer Institute (NCI) that funds early-stage postdoctoral researchers in cancer-related fields to transition to independent research careers. The award provides a mentored phase (K99) followed by an independent phase (R00), supporting investigators who do not require an extended period of supervised training beyond their doctoral degrees. Eligible applicants must hold a research or clinical doctoral degree and be postdoctoral fellows who have not yet established independent research careers. The March 11, 2026 due date applies; award amounts vary by project.